Back
Couchbase Vs. Neurogene Industry Stock Comparison
Sell
23
BASE
Couchbase
Last Price:
$15.26
Seasonality Move:
-1.73%
Sell
12
NGNE
Neurogene
Last Price:
$22.57
Seasonality Move:
18.83%
Sell
23
Couchbase (BASE)
is a Sell
Is Couchbase a Buy, Sell or Hold?
-
BASE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NGNE Stock Price Chart
BASE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.86 | Sell |
Relative Strength Index (14 RSI): | 34.3 | Sell |
Chaikin Money Flow: | 374464 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.71 - 20.37) | Sell |
Bollinger Bands (100): | (15.1 - 18.9) | Sell |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.64 | Sell |
Relative Strength Index (14 RSI): | 40.23 | Sell |
Chaikin Money Flow: | -23511 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.09 - 26.45) | Sell |
Bollinger Bands (100): | (26.19 - 50.01) | Sell |
BASE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.61 | Sell |
20-day SMA: | 17.52 | Sell |
50-day SMA: | 17.58 | Sell |
200-day SMA: | 19.9 | Sell |
8-day EMA: | 15.76 | Sell |
20-day EMA: | 16.78 | Sell |
50-day EMA: | 17.28 | Sell |
200-day EMA: | 18.67 | Sell |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.05 | Sell |
20-day SMA: | 23.34 | Sell |
50-day SMA: | 37.38 | Sell |
200-day SMA: | 37.89 | Sell |
8-day EMA: | 22.93 | Sell |
20-day EMA: | 25.32 | Sell |
50-day EMA: | 32.11 | Sell |
200-day EMA: | 35.01 | Sell |
Couchbase Earnings Growth & BASE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.01 per share, an increase this year of $0.41 per share, and an increase next year of $0.37 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.
Couchbase Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |